Regulation of GSK-3 Activity as A Shared Mechanism in Psychiatric Disorders
Glycogen synthase kinase-3 (GSK-3), a member of the serine/threonine kinase family was first identified as an inhibitor of the metabolic enzyme glycogen synthase and is now accepted as a widely influential enzyme responsible for many intracellular regulatory mechanisms with over 50 known substrates...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Mesut Çetin
2021-02-01
|
| Rangatū: | Psychiatry and Clinical Psychopharmacology |
| Ngā marau: | |
| Urunga tuihono: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/2863 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|